Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 138, Issue -, Pages -Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2021.111472
Keywords
CDGSH iron-sulfur domain2 (Cisd2); Senescence related; Cancer; Age-related diseases; Biomarker
Funding
- National Natural Science Foundation of China [31960175]
- Gansu Youth Science and Technology Fund Program [18JR3RA331]
Ask authors/readers for more resources
Cisd2 plays a crucial regulatory role in human aging-related diseases and various cancers, with its expression profile linked to clinical characteristics and potential therapeutic implications.
CDGSH iron-sulfur domain 2 (Cisd2) is an evolutionarily conserved protein that plays an important regulatory role in aging-related diseases and cancers. Since its discovery, Cisd2 has been identified as a regulatory factor for the aging of the human body and the regulation of mammalian lifespan. Cisd2 is also an oncoprotein that regulates the occurrence and development of cancer. Cisd2 mediates the occurrence of diseases related to human aging and the proliferation, differentiation, metastasis, and invasion of various cancer cells through various mechanisms. Multiple studies have shown that Cisd2 expression is related to the clinical characteristics of agingrelated diseases and patients with cancer, and its expression profile is a novel diagnostic and prognostic biomarker for a variety of human diseases. Modulating the expression or function of Cisd2 may be a potential treatment strategy for different diseases. In this review, we summarize the role of Cisd2 in human aging-related diseases and various cancers, as well as the biological functions, underlying mechanisms, and potential clinical significance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available